Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is caused by changes in the blood vessels of the retina. In some people with diabetic retinopathy, blood vessels may swell and leak fluid.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
In other people, abnormal new blood vessels grow on the surface of the retina. The retina is the light-sensitive tissue at the back of the eye. A healthy retina is necessary for good vision. Diabetic retinopathy usually affects both eyes. People who have diabetic retinopathy often don't notice changes in their vision in the disease's early stages. But as it progresses, diabetic retinopathy usually causes vision loss that in many cases cannot be reversed. It is an ocular manifestation of diabetes, a systemic disease, which affects up to 80 percent of all patients who have had diabetes for 10 years or more. Despite these intimidating statistics, research indicates that at least 90% of these new cases could be reduced if there was proper and vigilant treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy.
Global Diabetic Retinopathy Market is expected to reach USD 10.11 billion by 2022, according to a new study by Grand View Research Inc. Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes. The treatment line selection for diabetic retinopathy depends on the severity of the condition and may require intraocular injections, anti VEGF drugs, laser surgery or vitrectomy. Increasing incidences of diabetes, rising geriatric population base and the growing demand for early detection are some high impact rendering drivers of the diabetic retinopathy market.
International symposium and workshops
Aug 22-24, 2016, Sao Paulo, Brazil
November 02-04, 2015 Atlanta, Georgia, USA
February 29-March 02, 2016 Philadelphia, USA
June 06-08, 2016 Dallas, USA
Dec 5-7, 2016, Baltimore, USA
Nov 14-16, 2016, Dubai, UAE
Oct 20-22, 2016, Dubai, UAE
September 29-October 1, 2016, Toronto, Canada
Oct 17-19, 2016, Kuala Lumpur, Malaysia
Aug 22-24, 2016, Kuala Lumpur, Malaysia
Aug 8-10, 2016, Birmingham, UK
July 14-16, 2016, Cologne, Germany
July 11-13, 2016, Brisbane, Australia
Feb 29-Mar 2, 2016, Philadelphia, USA
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on October 3, 2022